Epstein Secrets

m 1988-1994, I worked in the Public Integrity Section of the Criminal Division. While working there, I received two Special Achievement Awards for Meritorious Acts and Service from the Department of Justice. EFTA00205055 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Docket 05/03/2011 Page 14 of 31 Page 2 of 4

nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic

m 1988-1994, I worked in the Public Integrity Section of the Criminal Division. While working there, I received two Special Achievement Awards for Meritorious Acts and Service from the Department of Justice. EFTA00205086 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Docket 05/03/2011 Page 14 of 31 Page 2 of 4

nistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy tests on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as synopses of data from clinical trials, the communic

m 1988-1994, I worked in the Public Integrity Section of the Criminal Division. While working there, I received two Special Achievement Awards for Meritorious Acts and Service from the Department of Justice. EFTA00230049 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Dodket 05/03/2011 Page 14 of 31 Page 2 of 4

inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic

m 1988-1994, I worked in the Public Integrity Section of the Criminal Division. While working there, I received two Special Achievement Awards for Meritorious Acts and Service from the Department of Justice. 08-80736-CV-MARRA 000803 EFTA00230627 Case 9:08-cv-80736-KAM Document 79-1 Entered on FLSD Dodket 05/03/2011 P

inistration (FDA) sends a letter to the agency in which he sets out certain data from safety and efficacy test on a new drug for which his employer, ABC Drug Co., is seeking FDA approval. Even if the letter is confined to arguably "factual" matters, such as syncpses of data from clinical trials, the communic